Bioresorbable Scaffolds Market

The Bioresorbable Scaffolds Market Share is projected to reach USD 2,920.6 Million by 2030 at 19.9% CAGR during the forecast period.

Bioresorbable scaffolds are medical devices used in widening clogged arteries or veins and primarily find use in cardiovascular surgeries. They have gained prominence in recent years due to metallic scaffolds causing an infection within the body and resulting in patient death. Developments of bioresorbable scaffolds to reach the level of drug-eluting stents are likely to drive the global bioresorbable scaffolds market.

Increasing government support and investment for better medical techniques and breakthroughs of techniques in cardiovascular surgeries can fuel the bioresorbable scaffolds market. Biodegradable nature of these stents which allow for recovery of vessel vasoreactivity can play a pivotal role in the market in the coming years. Use of polymers as a coating for stents for providing adequate radial strength will open up new growth avenues.

But availability of alternative therapies can restrain market growth.

Bioresorbable Scaffolds Market Outlook and Research Report, by Material (absorbable magnesium stent (AMS), polymeric scaffold, poly carbonate scaffold and others), by Types (drug eluting coronary scaffolds, everolimus-eluting device, novolimus-eluting device, sirolimus-eluting device, paclitaxel-eluting device), by Applications (peripheral vascular intervention, regulation of blood flow and others) by End Users (hospitals, clinics and others) - Forecast till 2030

Key Players

Prominent players included in MRFR’s report are Abbott (US), Medtronic (UK), Boston Scientific Corporation (US), Biotronik (Germany), Elixir Medical Corporation (US), REVA Medical, Inc (US), Amaranth Medical, Inc. (US), Kyoto Medical Planning Co. Ltd. (Japan), Xenogenics Corporation (US), B. Braun (Germany), Cardinal Health. (US), Lombard Medical, Inc (UK), Translumina (Germany), MicroPort Scientific Corporation (China) and TERUMO CORPORATION (Japan)

Market Segmentation

The global bioresorbable scaffolds market is segmented by material, type, application, and end-user.

By material, it is segmented into polycarbonate scaffold, polymeric scaffold, absorbable magnesium stent (AMS), and others. Polymeric and polycarbonate scaffold segments can account for a large market share due to increasing use of PCI procedures and preference of polymer-based stents.

By type, it is segmented into paclitaxel-eluting device, drug eluting coronary scaffolds, sirolimus-eluting device, everolimus-eluting device, and novolimus-eluting device.

By application, it is segmented into regulation of blood flow control, peripheral vascular intervention, and others.

By end-user, it is segmented into clinics, hospitals, and others. Hospitals can account for a large market share due to preference of hospitals by patients for diagnostic and surgical procedures. Rapid rate of cardiovascular surgeries can drive the segment growth exponentially.

Regional Analysis

Europe, the Middle East & Africa (MEA), Asia Pacific, and the Americas are regions covered in the bioresorbable scaffolds market report.

The Americas accounted for close to 40% market share in 2016. Large geriatric population, large share of the regional population plagued by obesity and diabetes, and presence of prominent market players are factors bound to propel demand for bioresorbable scaffolds in the region. High stress levels, lack of exercise, and deskbound lifestyle of patients are other drivers positively impacting the bioresorbable scaffolds market. High incidence of pulmonary artery disease, coronary artery disease, and other diseases which can harden or weaken arteries can also be a vital growth determinant in the market.

Europe has the second largest market share due to a large healthcare budget, patient-friendly reimbursement policies, and presence of developed economies of Italy, France, and Germany. Rising focus of players in the region to focus on clinical trials of stents and rise of pulmonary coronary interventional (PCI) procedures

The APAC region can account for the fastest growth rate due to a large patient pool, large number of skilled surgeons, and high incidence of cardiovascular disorders. Furthermore, reduction in prices of stents by governments for making it affordable for patients across all economic strata can bode well for the market within the region.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com